Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Navani A, Manchikanti L, Albers SL, Latchaw RE, Sanapati J, Kaye AD, Atluri S, Jordan S, Gupta A, Cedeno D, Vallejo A, Fellows B, Knezevic NN, Pappolla M, Diwan S, Trescot AM, Soin A, Kaye AM, Aydin SM, Calodney AK, Candido KD, Bakshi S, Benyamin RM, Vallejo R, Watanabe A, Beall D, Stitik TP, Foye PM, Helander EM, Hirsch JA.

Pain Physician. 2019 Jan;22(1S):S1-S74.

2.

Challenges and concerns of persistent opioid use in cancer patients.

Manchikanti L, Manchikanti KN, Kaye AD, Kaye AM, Hirsch JA.

Expert Rev Anticancer Ther. 2018 Jul;18(7):705-718. doi: 10.1080/14737140.2018.1474103. Epub 2018 May 14. Review.

PMID:
29739242
3.

Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.

Cornett E, Novitch MB, Kaye AD, Pann CA, Bangalore HS, Allred G, Bral M, Jhita PK, Kaye AM.

Postgrad Med. 2017 Sep;129(7):715-724. doi: 10.1080/00325481.2017.1362938. Epub 2017 Aug 10. Review.

PMID:
28770640
4.

Medication-Induced Tardive Dyskinesia: A Review and Update.

Cornett EM, Novitch M, Kaye AD, Kata V, Kaye AM.

Ochsner J. 2017 Summer;17(2):162-174. Review.

5.

Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).

Kaye AD, Jones MR, Kaye AM, Ripoll JG, Jones DE, Galan V, Beakley BD, Calixto F, Bolden JL, Urman RD, Manchikanti L.

Pain Physician. 2017 Feb;20(2S):S111-S133.

6.

Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.

Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, Calixto F, Bolden JL, Urman RD, Manchikanti L.

Pain Physician. 2017 Feb;20(2S):S93-S109. Review.

7.

Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, Blank S, Pampati V, Abdi S, Grider JS, Kaye AD, Manchikanti KN, Cordner H, Gharibo CG, Harned ME, Albers SL, Atluri S, Aydin SM, Bakshi S, Barkin RL, Benyamin RM, Boswell MV, Buenaventura RM, Calodney AK, Cedeno DL, Datta S, Deer TR, Fellows B, Galan V, Grami V, Hansen H, Helm Ii S, Justiz R, Koyyalagunta D, Malla Y, Navani A, Nouri KH, Pasupuleti R, Sehgal N, Silverman SM, Simopoulos TT, Singh V, Solanki DR, Staats PS, Vallejo R, Wargo BW, Watanabe A, Hirsch JA.

Pain Physician. 2017 Feb;20(2S):S3-S92.

8.

Non-medical use of prescription opioids is associated with heroin initiation among US veterans.

Ruan X, Luo JJ, Kaye AM, Kaye AD.

Addiction. 2017 Apr;112(4):727-728. doi: 10.1111/add.13639. Epub 2017 Jan 25. No abstract available.

PMID:
28120357
9.

Comment.

Ruan X, Luo JJ, Kaye AM, Kaye AD.

Ann Pharmacother. 2017 Mar;51(3):273. doi: 10.1177/1060028016675353. Epub 2016 Oct 15. No abstract available.

PMID:
27742761
10.

Current State of Opioid Therapy and Abuse.

Manchikanti L, Kaye AM, Kaye AD.

Curr Pain Headache Rep. 2016 May;20(5):34. doi: 10.1007/s11916-016-0564-x. Review.

PMID:
27048483
11.

The identification of cis-regulatory elements: A review from a machine learning perspective.

Li Y, Chen CY, Kaye AM, Wasserman WW.

Biosystems. 2015 Dec;138:6-17. doi: 10.1016/j.biosystems.2015.10.002. Epub 2015 Oct 21. Review.

PMID:
26499213
12.

Hydrocodone bitartrate for chronic pain.

Manchikanti L, Atluri S, Kaye AM, Kaye AD.

Drugs Today (Barc). 2015 Jul;51(7):415-27. doi: 10.1358/dot.2015.51.7.2361328. Review.

PMID:
26261844
13.

Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review.

Beakley BD, Kaye AM, Kaye AD.

Pain Physician. 2015 Jul-Aug;18(4):395-400. Review.

14.

Rhabdomyolysis: pathogenesis, diagnosis, and treatment.

Torres PA, Helmstetter JA, Kaye AM, Kaye AD.

Ochsner J. 2015 Spring;15(1):58-69. Review.

15.

Drug-induced acute pancreatitis: a review.

Jones MR, Hall OM, Kaye AM, Kaye AD.

Ochsner J. 2015 Spring;15(1):45-51. Review.

16.

Perioperative analgesia and the effects of dietary supplements.

Abe A, Kaye AD, Gritsenko K, Urman RD, Kaye AM.

Best Pract Res Clin Anaesthesiol. 2014 Jun;28(2):183-9. doi: 10.1016/j.bpa.2014.04.002. Epub 2014 May 9. Review.

PMID:
24993438
17.

Serotonin syndrome.

Volpi-Abadie J, Kaye AM, Kaye AD.

Ochsner J. 2013 Winter;13(4):533-40. Review.

18.

Basic concepts in opioid prescribing and current concepts of opioid-mediated effects on driving.

Kaye AM, Kaye AD, Lofton EC.

Ochsner J. 2013 Winter;13(4):525-32. Review.

19.

Benzodiazepine pharmacology and central nervous system-mediated effects.

Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD.

Ochsner J. 2013 Summer;13(2):214-23.

20.

Age-dependent responsiveness of human female bone cells to vitamin D analog and PTH.

Somjen D, Katzburg S, Kaye AM, Posner GH.

J Endocrinol Invest. 2013 Feb;36(2):118-22.

PMID:
23481611
21.

QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes.

Kaye AD, Volpi-Abadie J, Bensler JM, Kaye AM, Diaz JH.

J Anesth. 2013 Aug;27(4):575-87. doi: 10.1007/s00540-013-1564-1. Epub 2013 Feb 15. Review.

PMID:
23412014
22.

American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.

Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S 2nd, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW; American Society of Interventional Pain Physicians.

Pain Physician. 2012 Jul;15(3 Suppl):S67-116.

23.

American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.

Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S 2nd, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW; American Society of Interventional Pain Physicians.

Pain Physician. 2012 Jul;15(3 Suppl):S1-65.

24.

Sleep physiology, abnormal States, and therapeutic interventions.

Wickboldt AT, Bowen AF, Kaye AJ, Kaye AM, Rivera Bueno F, Kaye AD.

Ochsner J. 2012 Summer;12(2):122-34.

25.
26.

Anticoagulants: newer ones, mechanisms, and perioperative updates.

Gayle JA, Kaye AD, Kaye AM, Shah R.

Anesthesiol Clin. 2010 Dec;28(4):667-79. doi: 10.1016/j.anclin.2010.08.013. Review.

PMID:
21074744
27.

The response of creatine kinase specific activity in rat pituitary to estrogenic compounds and vitamin d less-calcemic analogs.

Somjen D, Mirsky N, Tamir S, Vaya J, Posner GH, Kaye AM.

Int J Cell Biol. 2009;2009:273651. doi: 10.1155/2009/273651. Epub 2009 Sep 10.

28.

DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM).

Somjen D, Katzburg S, Knoll E, Hendel D, Stern N, Kaye AM, Yoles I.

J Steroid Biochem Mol Biol. 2007 May;104(3-5):252-8. Epub 2007 Mar 14.

PMID:
17428655
29.
30.
31.

Nutraceuticals: potential roles and potential risks for pain management.

Kaye AD, Kaye AM, Hegazi A, Sabar R, Deaton B, Powell J, Hofbauer R.

Pain Pract. 2002 Jun;2(2):122-8.

PMID:
17147685
32.

Responsiveness to estradiol-17beta and to phytoestrogens in primary human osteoblasts is modulated differentially by high glucose concentration.

Somjen D, Katzburg S, Kohen F, Gayer B, Sharon O, Hendel D, Kaye AM.

J Steroid Biochem Mol Biol. 2006 May;99(2-3):139-46. Epub 2006 Apr 18.

PMID:
16621514
33.
34.

Responsiveness to phytoestrogens in primary human osteoblasts is modulated differentially by a "less-calcemic" analog of 1,25 dihydroxyvitamin D(3): JK 1624F(2)-2 (JKF).

Somjen D, Katzburg S, Kohen F, Gayer B, Sharon O, Hendel D, Posner GH, Kaye AM.

J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):139-46. Epub 2006 Jan 10.

PMID:
16406510
35.

Membranal effects of phytoestrogens and carboxy derivatives of phytoestrogens on human vascular and bone cells: new insights based on studies with carboxy-biochanin A.

Somjen D, Kohen F, Lieberherr M, Gayer B, Schejter E, Katzburg S, Limor R, Sharon O, Knoll E, Posner GH, Kaye AM, Stern N.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):293-303. Epub 2005 Feb 5.

PMID:
15860273
36.

Differentiation of cultured mice bone marrow into osteoblast-like cells results in acquisition of sex-specific responsiveness to gonadal steroids.

Berger E, Bleiberg I, Weisman Y, Harel A, Kaye AM, Somjen D.

J Endocrinol Invest. 2004 Jul-Aug;27(7):622-8.

PMID:
15505984
37.

Estrogenic activity of glabridin and glabrene from licorice roots on human osteoblasts and prepubertal rat skeletal tissues.

Somjen D, Katzburg S, Vaya J, Kaye AM, Hendel D, Posner GH, Tamir S.

J Steroid Biochem Mol Biol. 2004 Aug;91(4-5):241-6.

PMID:
15336701
38.

Modulation of response to estrogens in cultured human female bone cells by a non-calcemic Vitamin D analog: changes in nuclear and membranal binding.

Somjen D, Katzburg S, Sharon O, Kaye AM, Gayer B, Kohen F, Hendel D, Posner GH.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):393-5.

PMID:
15225807
39.
40.

Protein synthesis in nuclei: when did the story start?

Gozes I, Walker MD, Kaye AM, Littauer UZ.

J Mol Neurosci. 2002 Jun;18(3):167. No abstract available.

PMID:
12059034
41.

Selective anabolic effects of muteins of mid-region PTH fragments on skeletal tissues of prepubertal rats.

Kim TY, Vargas V, Mayer H, Somjen D, Kaye AM.

Bone. 2002 Jan;30(1):78-84.

PMID:
11792568
42.
43.

Paradoxical interactions among estrogen receptors, estrogens and SERMS: mutual annihilation and synergy.

Kaye AM, Spatz M, Waisman A, Sasson S, Tamir S, Vaya J, Somjen D.

J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):85-93.

PMID:
11384866
44.

The hormonal milieu in early stages of bone cell differentiation modifies the subsequent sex-specific responsiveness of the developing bone to gonadal steroids.

Berger E, Bleiberg I, Weisman Y, Lifschitz-Mercer B, Leider-Trejo L, Harel A, Kaye AM, Somjen D.

J Bone Miner Res. 2001 May;16(5):823-31.

45.

Age and gender specific stimulation of creatine kinase specific activity by gonadal steroids in human bone-derived cells in culture.

Katzburg S, Ornoy A, Hendel D, Lieberherr M, Kaye AM, Somjen D.

J Endocrinol Invest. 2001 Mar;24(3):166-72.

PMID:
11314745
46.

Herbal medicines: current trends in anesthesiology practice--a hospital survey.

Kaye AD, Clarke RC, Sabar R, Vig S, Dhawan KP, Hofbauer R, Kaye AM.

J Clin Anesth. 2000 Sep;12(6):468-71.

PMID:
11090733
47.

The relationship of inflammation in the papanicolaou smear to Chlamydia trachomatis infection in a high-risk population.

Paler RJ Jr, Simpson DR, Kaye AM, Gunn S, Felix JC.

Contraception. 2000 Mar;61(3):231-4.

PMID:
10827338
49.

An Estrogen Receptor Paradox: Why Do Estrogen and Tamoxifen Antagonize Each Other's Activity?

Kaye AM, Somjen D.

Trends Endocrinol Metab. 1999 Aug;10(6):251. No abstract available.

PMID:
10407400
50.

Supplemental Content

Support Center